Skip to main content
. 2023 Jun 26;10:1217745. doi: 10.3389/fcvm.2023.1217745

Table 2.

Procedural characteristics and rhythm outcome.

All (N = 30) Ostial-PFA (N = 15) WACA-PFA (N = 15) p-value
PFA procedure
Procedure time (min) 66 (60, 74) 65 (50, 73) 66 (60, 73) 0.29
Fluoroscopy time (min) 11 (10, 15) 11 (9, 13) 13 (10, 16) 0.26
Dose area product (cGv/cm2) 396 (304, 623) 413 (269, 603) 382 (339, 637) 0.71
Contrast medium (ml) 40 (40, 50) 40 (30, 50) 40 (40, 50) 0.35
Heparin (IEx1000) 17 (13, 20) 17 (14, 20) 15 (12, 20) 0.35
Propofol (1% mg) 575 (500, 748) 500 (470, 745) 600 (500, 755) 0.78
Midazolam (mg) 2.5 (2, 4) 2.5 (2, 4) 2.5 (2, 3) 0.25
Fentanyl (mg) 50 (50, 50) 50 (50, 63) 50 (50, 50) 0.71
Left atrial mapping
Catheter dwell time (min) 19 (15, 24) 19 (16, 26) 18 (16, 21) 0.47
PFA catheter size 31 mm (%) 33 20 47 0.09
Pre-mapping point density 2,344 ± 1,202 2,178 ± 1,515 2,498 ± 839 0.48
Post-mapping point density 2,819 ± 1,534 2,719 ± 1,521 2,905 ± 1,592 0.76
PFA lesion size (cm2) 40.4 ± 9.3 35.1 ± 7.2 45.5 ± 8.3 0.001a
LA wall isolation (n, %) 0 (0) 11/15 (73) 0.001a
Rhythm outcome
Freedom from arrhythmia (%) 90 87 94 0.68
Re-ablation (n, %) 2/30 (7%) 2/15 (13%) 0 (0%) 0.14

PFA, pulsed field ablation; WACA, wide antral circumferential ablation; LA, left atrial.

Continuous data are given in median and interquartile range (Q1, Q3) and categorical data are given in percentage of N.

a

Statistically significant.